Home › Sistema immunitario e disturbi › Oregon › Portland
Studi clinici su Sistema immunitario e disturbi a Portland, OR
9 studi su Sistema immunitario e disturbi cercano partecipanti presso sedi a Portland e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
In reclutamentoFase 1
- Oregon Health & Science University, Portland
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
In reclutamentoFase 3
- Oregon Health & Science University, Portland
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
In reclutamentoStudio osservazionale
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Portland VA Medical Center, Portland
- e altri 1
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
In reclutamentoFase 3
- Oregon Health & Science University, Portland
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
In reclutamentoFase 1
- Providence Portland Medical Center, Portland
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
In reclutamentoFase 2
- Inmagene Site 3, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
In reclutamentoFase 2
- Oregon Health and Science University, Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
In reclutamentoFase 1/2
- Providence Neurological Specialties West, Portland
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
In reclutamentoFase 2
- Oregon Health and Science University, Portland
Studi su Sistema immunitario e disturbi in altre città
- Washington, DC13 studi
- New York City, NY12 studi
- Boston, MA10 studi
- Philadelphia, PA10 studi
- Atlanta, GA9 studi
- Houston, TX9 studi
- Cleveland, OH8 studi
- Chicago, IL8 studi
- Los Angeles, CA8 studi
- Milwaukee, WI6 studi
- Seattle, WA6 studi
- Cedar Rapids, IA6 studi
Altri studi a Portland
- Cancro del polmone non a piccole cellule46 studi
- Cancro (tutti i tipi)34 studi
- Cancro alla prostata33 studi
- Cancro al seno33 studi
- Cancro metastatico29 studi
- Cancro colorettale28 studi
- Cancro ovarico27 studi
- Cancro ai polmoni26 studi
- Leucemia mieloide acuta25 studi
- Cancro dell'endometrio24 studi
- Carcinoma a cellule squamose della testa e del collo19 studi
- Cancro pancreatico19 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.